(Rs. in Million) |
| Quarter ended | Year to Date | Year ended | |||||||
| 202603 | 202503 | % Var | 202603 | 202503 | % Var | 202603 | 202503 | % Var | |
| Sales | 3383.72 | 3287.53 | 2.93 | 13487.36 | 13117.84 | 2.82 | 13487.36 | 13117.84 | 2.82 |
| Other Income | 277.29 | 320.50 | -13.48 | 1129.65 | 1241.92 | -9.04 | 1129.65 | 1241.92 | -9.04 |
| PBIDT | 395.16 | 497.74 | -20.61 | 2104.25 | 2626.91 | -19.90 | 2104.25 | 2626.91 | -19.90 |
| Interest | 25.93 | 26.26 | -1.26 | 100.38 | 153.09 | -34.43 | 100.38 | 153.09 | -34.43 |
| PBDT | 342.12 | 471.48 | -27.44 | 1938.68 | 2473.82 | -21.63 | 1938.68 | 2473.82 | -21.63 |
| Depreciation | 124.21 | 100.93 | 23.07 | 455.03 | 395.45 | 15.07 | 455.03 | 395.45 | 15.07 |
| PBT | 217.91 | 370.55 | -41.19 | 1483.65 | 2078.37 | -28.61 | 1483.65 | 2078.37 | -28.61 |
| TAX | 65.94 | 94.66 | -30.34 | 367.25 | 468.39 | -21.59 | 367.25 | 468.39 | -21.59 |
| Deferred Tax | 33.28 | 12.05 | 176.18 | -3.69 | -7.14 | -48.32 | -3.69 | -7.14 | -48.32 |
| PAT | 151.97 | 275.89 | -44.92 | 1116.40 | 1609.98 | -30.66 | 1116.40 | 1609.98 | -30.66 |
| Equity | 306.21 | 306.21 | 0.00 | 306.21 | 306.21 | 0.00 | 306.21 | 306.21 | 0.00 |
| PBIDTM(%) | 11.68 | 15.14 | -22.87 | 15.60 | 20.03 | -22.09 | 15.60 | 20.03 | -22.09 |
| Company Name | CMP |
|---|---|
| Sun Pharma. Inds. | 1903.00 |
| Dr. Reddys Labs. | 1353.75 |
| Cipla | 1452.35 |
| Zydus Lifesciences | 1152.90 |
| Lupin | 2489.85 |
| View more.. | |
Start Research-backed Investing ...Now. Subscribe to Sapphire
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: